Home›Research›Compare›Cetrorelix vs Gonadorelin
Peptide ComparisonCetrorelix vs Gonadorelin
Both are Reproductive & Hormonal peptides.
Cetrorelix
Cetrotide
Half-life: ~62 hours
1 providers listed
Gonadorelin
GnRH
Half-life: ~2-4 minutes
26 providers listed
Cetrorelix is FDA-approved, while Gonadorelin is not evaluated — the clearest structural difference between them.
Cetrorelix
Half-life
~62 hours
Gonadorelin
Half-life
~2-4 minutes
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Cetrorelix |
| Further along in FDA review | Cetrorelix |
| Less frequent dosing (longer half-life) | Cetrorelix |
| More provider options (1 vs 26) | Gonadorelin |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Cetrorelix
Gonadorelin
Cetrorelix
GnRH Agonists and Antagonists in IVF/ICSI Cycles of PCOS Women: A Network Meta-Analysis.
Optimal GnRH antagonist protocol for ovarian stimulation during ART: systematic review and network meta-analy…
Efficacy and safety of different cetrorelix doses in the luteal phase for preventing ovarian hyperstimulation…
Effects of half-dose and full-dose GnRH antagonists on IVF-ET outcomes: a retrospective study
+3 more
Gonadorelin
Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and fu…
Effect of post-insemination GnRH analogue administration on pregnancy rates in repeat-breeder cows: compariso…
Increasing gonadorelin hydrochloride dose at the first GnRH of breeding Ovsynch enhances luteinizing hormone…
About Cetrorelix
Competitive GnRH receptor antagonist; immediately blocks pituitary GnRH receptors; rapidly suppresses LH/FSH without initial flare effect; used for controlled hormonal suppression
About Gonadorelin
Synthetic GnRH that binds pituitary GnRH receptors; pulsatile dosing stimulates LH/FSH release; used to maintain HPG axis during TRT
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Cetrorelix
Source: FDA label
Under clinical review
Being verified by our medical team before we display monitoring guidance for this peptide.
Gonadorelin
No established clinical contraindications
Standard reproductive endocrinology panels establish HPG axis baseline. LH and FSH confirm pituitary response to gonadorelin; testosterone, E2, and SHBG reflect downstream gonadal output.
Cetrorelix
Not enough vendor pricing yet.
Gonadorelin
Where to source these peptides
Cetrorelix
1 listed
Browse directory →
Providers offeringGonadorelin
26 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Reproductive & Hormonal Comparisons
Browse all peptides →Explore Cetrorelix
Explore Gonadorelin
Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Cetrorelix vs Gonadorelin — Per-mg Price Comparison. Retrieved September 13, 2026, from https://peptidebase.io/peptides/compare/cetrorelix/gonadorelin